Cerebrotendinous xanthomatosis (CTX) is a rare disorder evident in all patients using a FLAIR sequence. On proton magnetic resonance (MR) spectroscopy, significant due to an inherited defect in the metabolic pathway of decreases in N-acetylaspartate resonance intensities cholesterol. Early diagnosis of the disease is particularly (P < 0.0001) and increases in lactate MR signals (P < 0.05) important as patients benefit from therapy with were found in the group of CTX patients in large volumes chenodeoxycholic acid. Although the disease is clinically of interest localized above the lateral brain ventricles characterized by the concomitant presence of tendon and in the cerebellar hemispheres. Cerebral values of xanthomas, juvenile cataracts and progressive neuro-N-acetylaspartate resonance intensities showed a close logical impairment, clinical features may vary greatly. correlation with patients' disability (Spearman rank Neuroradiological studies have suggested that the bilateral correlation ⍧ -0.78, P < 0.005). These results suggest abnormality of the dentate nuclei could be typical of this that MR abnormalities in the dentate nuclei may be disease. However, this finding has been seen inconsistently evident consistently in patients with CTX. Proton MR on conventional MRI. The dynamic of the CNS pathology spectroscopy data demonstrated widespread axonal in CTX is complex, and whether demyelination or damage (as shown by the decrease in N-acetylaspartate) axonopathy has primary importance in the pathogenesis and diffuse brain mitochondrial dysfunction (as shown of CTX pathology is not known. To clarify both by the increase in brain parenchymal lactate) in patients neuroradiological and pathological issues, we performed with CTX. The close correlation seen between values combined brain MRI and spectroscopy examinations of the putative axonal marker N-acetylaspartate and on 12 CTX patients. On conventional MRIs, bilateral patients' disability scores suggests that proton MR hyperintensities of the dentate nuclei were clearly seen in spectroscopy can provide a useful measure of disease outcome in CTX. nine out of 12 patients on T 2 -weighted MRIs, but were
Introduction
Cerebrotendinous xanthomatosis (CTX) is a rare inherited various tissues (Bjorkhem and Boberg, 1995; . disorder due to a systemic defective activity of the mitochondrial enzyme sterol 27-hydroxylase. This enzyme
The abnormal metabolism of cholestanol is considered responsible for the clinical manifestations of CTX. Clinical plays an important role in the metabolic pathway of cholesterol by catalysing the oxidation of sterol intermediates. symptoms may be evident in different organ systems (Cruysberg et al., 1991; Wevers et al., 1992; Berginer et al. , Consequently, patients with sterol 27-hydroxylase deficiency have defective bile acid synthesis (with increases in cholic 1993a, b; Federico et al., 1993; Dotti et al., 1998) , but are usually dominated by the classical acid and decreases in chenodeoxycholic acid) and abnormally high levels of cholestanol in plasma, urine, faeces and triad of the disease: juvenile cataracts, tendon xanthomas and progressive neurological impairment (Federico and Dotti, in this rare metabolic disorder, (ii) identifying potential neuroradiological markers of the disease, and (iii) providing 1996; Verrips et al., 2000) . The diagnosis of CTX can be made biochemically [detected by the increased serum level putative markers of disease outcome. of cholestanol (Berginer et al., 1993a) ] and genetically [detected by molecular defects in the sterol 27-hydroxylase gene Chen et al., 1998; Verrips Methods et al., 2000) ]. Early diagnosis is imperative in patients with
Patient population
CTX, as the pharmacological treatment with chenoTwelve adult patients with CTX from eight families (eight deoxycholic acid (or with a combination of chenodeoxycholic females and four males, age range 32-55 years) were studied. acid and HMG-CoA reductase inhibitors) has been shown to All patients met the clinical criteria for CTX and had a blood slow or even reverse the progression of the disease (Berginer level of cholestanol Ͼ1 mg/dl Dotti, 1996). et al., 1984; Pedley et al., 1985; Federico and Dotti, 1994;  DNA point mutations or deletions in the sterol 27-hydroxylase Verrips et al., 1999b) .
gene were detected in all patients (Table 1) . A complete The combination of cataract, tendon xanthomas and clinical evaluation was performed on the day of the MRI progressive neurological impairment is peculiar and strongly examination by an experienced neurologist (M.T.D.), who suggests the diagnosis of CTX. However, although all assessed the patients' clinical disability using Expanded classical features of the disease are evident in the majority Disability Status Scale (EDSS) scores (Kurtzke, 1983) of CTX patients, these may vary considerably in onset, (Table 1) . At the time of the clinical and MRI examinations, degree and extent (Berginer et al., 1993a) . Moreover, a all patients showed the classic triad of the disease. Ten out number of patients may not have tendon xanthomas at the of 12 CTX patients had been treated with chenodeoxycholic onset of the disease or may never develop them (Siebner acid for 7-14 years (Table 1) , whereas the remaining two et Gilad et al., 1999; Verrips et al., 1999a) .
patients were not taking any medication (Patients 2 and 10 Biochemical and genetic tests will often not be performed in in Table 1 ). The study was approved by the Ethics Committee patients without xanthomas, even if other clinical of the Faculty of Medicine of the University of Siena, and manifestations of the disease are present (Siebner et al., informed consent was obtained from all participating patients. 1996). It is therefore very important to find markers that can supplement clinical features in the characterization of the disease, ensuring early diagnosis in cases with atypical clinical manifestation.
MR examinations
Each patient underwent conventional MRI and single-voxel Conventional magnetic resonance MRI studies have shown focal or diffuse white matter abnormalities and different proton MRS examinations in a single session. These were obtained using a Philips Gyroscan NT operating at 1.5 T degrees of cerebral and cerebellar atrophy in brains of patients with CTX (Swanson and Cromwell, 1986; Bencze et al., (Philips Medical Systems, Best, The Netherlands). A sagittal survey image was used to identify the anterior commissure 1990; Fiorelli et al., 1990; Hokezu et al., 1992; Berginer et al., 1994; Dotti et al., 1994; Siebner et al., 1996) . These (AC) and posterior commissure (PC). A transverse dual spinecho sequence [repetition time (TR) ϭ 2300 ms, echo time MRI findings are non-specific as they can be found in many neurometabolic disorders. However, abnormal MR signals (TE) ϭ 2090 ms, slice thickness 5 mm) yielding proton density-weighted and T 2 -weighted images was acquired in around the dentate nuclei and in the surrounding white matter have been demonstrated in most of the CTX patients reported the transverse plane parallel to the AC-PC line. Turbo T 2 -weighted images in the sagittal plane (TR ϭ 3000 ms, in the literature and can be suggestive of this disorder (Valk and van der Knaap, 1996) . TE ϭ 120 ms, slice thickness 5 mm) and fluid-attenuated inversion recovery (FLAIR) images (TR ϭ 9000 ms, TE ϭ Conventional MRI detects brain lesions with great sensitivity, but does not provide specific information about 150 ms, slice thickness 5 mm) in the transverse plane were also acquired. the pathology underlying the detected lesions and is often not a good predictor of functional impairment or disability Conventional MRIs were used to position an intracranial volume of interest for spectroscopy. In each MR session, (Rudkin and Arnold, 1999) . Proton MR spectroscopy (MRS), by providing a non-invasive biochemical assay of living proton MR spectra were acquired from two different volumes of interest. First, a brick-shaped box measuring~70 mm tissues, can overcome some of these limitations (Arnold and Matthews, 1996) . Myelin and axonal integrity, as well as (anterioposterior) ϫ 50 mm (left-right) ϫ 20 mm (craniocaudal) was positioned just superior to the lateral ventricles brain oxidative metabolism, can be assessed easily in vivo by this MR technique, and its use in rare metabolic disorders ( Fig. 1) . After the first acquisition, a second volume of interest measuring~25 mm (anterioposterior) ϫ 50 mm (leftsuch as CTX may provide a better understanding of the complex dynamics of pathological changes. right) ϫ 20 mm (craniocaudal) was positioned in a central cerebellar region (Fig. 2 ). Brain volumes of interest were We therefore performed combined brain MRI and MRS examinations in a group of 12 patients with CTX with the positioned to include both grey and white matter of both hemispheres. These included the cerebral and cerebellar MRI aim of (i) evaluating in vivo brain metabolic changes occurring As ϭ aberrant splicing. *For references see Garuti et al., 1996. lesions, but mostly contained normal-appearing brain (Figs 1 software (Philips Medical Systems) as previously described (De Stefano et al., 1998) . The residual water signal was and 2).
Proton spectra were acquired using a 90°-180°-180°removed by applying the linear HSVD (Hankel singlar valve decomposition procedure) fitting method (de Beer et al., (PRESS) sequence for volume selection (Ordidge et al., 1987) (TR ϭ 2000 ms, TE ϭ 272 ms, 128 averages). 1992). A mild exponential filter, Fourier transformation and phase correction were applied prior to the quantification of Magnetic field homogeneity was optimized to a line width of~5 Hz over the volume of interest using the proton signal metabolites. These were determined by integration of peak areas between automatically determined frequency bounds from water. Water suppression was achieved by placing frequency-selective excitation pulses at the beginning of the relative to a polynomial baseline. Long echo time (TE ϭ 272 ms) MRS data allows the quantification of four main MRS sequence (Haase et al., 1985) . Post-processing of the raw data was done on a SUN/SPARC system using XUNspec1 resonance intensities (Arnold and Matthews, 1996) : (i) choline (Cho) at 3.2 p.p.m., mainly from choline-containing
Results
phospholipids (an indicator of cell membrane integrity); Conventional MRI data are summarized in Table 2 . Cerebral (ii) N-acetyl groups at 2.0 p.p.m., mainly N-acetylaspartate atrophy was evident at visual examination in nine out of 12 (NAA, a marker of axonal integrity); (iii) lactate (La), a CTX patients and cerebellar atrophy was seen in eight doublet at 1.3 p.p.m. divided by a characteristic splitting of patients. On both T 2 -weighted and FLAIR images, focal or 7 Hz, accumulating in pathological conditions such as diffuse white matter lesions were evident in both cerebral oxidative metabolism impairment and acute inflammation, and cerebellar hemispheres in the whole group of patients and barely distinguishable from the noise in single-voxel (Fig. 3 ). An abnormal MRI signal was clearly detected in MRS experiments in normal controls (Matthews et al., 1993;  the dentate nuclei and surrounding white matter in nine out De Stefano et al., 1995b) ; and (iv) creatine (Cr) at 3.0 p.p.m., of 12 CTX patients on T 2 -weighted MRI, but this was clearly expressing signal from both creatine and phosphocreatine. evident in all CTX patients on FLAIR images (Fig. 4) . Metabolite resonance intensity values were expressed as Proton MRS results are summarized in Table 3 . In the ratios with respect to Cr, which tends to be resistant to group of CTX patients, we found significant decreases in changes. Chemical shifts were calculated relative to NAA at brain NAA/Cr (cerebral NAA/Cr ϭ 2.43 Ϯ 0.27 in CTX 2.0 p.p.m. patients and 2.96 Ϯ 0.19 in normal controls, P Ͻ 0.0001; cerebellar NAA/Cr ϭ 1.47 Ϯ 0.13 in CTX patients and 1.85 Ϯ 0.10 in normal controls, P Ͻ 0.0001) ( Table 3 and Figs 1 and 2 ). Significant increases in La/Cr ratio were also
Statistical analysis
found in both brain volumes of interest (cerebral La/Cr ϭ Single-voxel MRS data relative to the patient group were 0.50 Ϯ 0.17 in CTX patients and 0.32 Ϯ 0.08 in normal compared with those of normal adult subjects (age range 22-controls, P Ͻ 0.001; cerebellar La/Cr ϭ 0.27 Ϯ 0.10 in CTX 56 years, 23 subjects for cerebral volume of interest and 13 patients and 0.18 Ϯ 0.04 in normal controls, P Ͻ 0.03) subjects for cerebellar volume of interest) using the non- (Table 3 and Figs 1 and 2) . Interestingly, the two patients parametric Kruskal-Wallis test of variance. Values of NAA/ who were not under pharmacological treatment showed the Cr relative to the patient group were correlated with their highest La/Cr values (Tables 1 and 3 ). corresponding EDSS scores using the non-parametric Patient values of Cho/Cr were within the normal limits in Spearman rank order correlation (SROC). Significance of the both brain regions (Table 3 and Figs 1 and 2) . In order to assess in vivo putative markers of disease data was established at P Ͻ 0.05. et al., 1994) . Thus, while we cannot exclude the presence of a chronic demyelinating process in brains of patients with CTX, the widespread decreases in NAA found in our study outcome, we compared different MRS indices with patients' clinical disability scores. A very close relationship was found strongly support the hypothesis that the basic enzymatic defect of this disorder leads to accumulation of brain metabolites that between individual EDSS scores and cerebral NAA/Cr values (SROC ϭ -0.78, P Ͻ 0.005) (Fig. 5) . In contrast, no close can be neurotoxic and may cause a primary neuroaxonal pathology (Soffer et al., 1995) . correlation with clinical disability was found for cerebral Cho/Cr and La/Cr resonance intensity ratios.
As immunohistochemical studies have found NAA exclusively in neurones and neuronal processes in the mature brain (Moffett et al., 1991; Simmons et al., 1991) , decreases in NAA have been interpreted as the expression of neuronal
Discussion
Conventional MRI examinations showed a nonor axonal damage. The fact that O2A progenitor cells (Urenjak et al., 1993) and mature oligodendroglial cells in culture homogeneous, hyperintense MR signal in dentate nuclei and surrounding cerebellar white matter in all CTX patients.
(Bhakoo and Pearce, 2000) can be induced to express NAA in vitro has raised some concerns about the specificity of Although this neuroradiological sign has been proposed recently as a characteristic feature of the disease (Valk and NAA changes in vivo. It is not clear whether these in vitro conditions are relevant to the situation in vivo. However, van der Knaap, 1996) , it has been reported inconsistently in most of the recent MR studies on patients with CTX (Hokezu future studies need to reconcile the data obtained from the use of antibodies with those obtained from the HPLC-and et al., 1992; Dotti et al., 1994; Siebner et al., 1996; Verrips et al., 1999a Verrips et al., , 2000 . In the present study, bilateral NMR-based analyses. As for the results presented here, oligodendrocyte density appears not to be reduced in normalabnormalities in the dentate nuclei were clearly detected only in nine out of 12 patients using T 2 -weighted MR images, but appearing white matter or chronic white matter lesions (Wolswijk, 1998) . Thus, the potential of NAA expression they were evident in all patients on FLAIR MRI (Fig. 4) . FLAIR sequences are increasingly used for clinical diagnosis in oligodendrocytes to confound our results appears to be minimal. as they have been shown to increase the sensitivity of MRI in detecting brain lesions in several white matter disorders
In the present study, significant increases in La in the cerebral and cerebellar regions of patients with CTX were (De Coene et al., 1992; Tourbah et al., 1996; Ashikaga et al., 1997; Kato et al., 1997; Kimura et al., 1997; Abe et al., found. The resonance intensity of La detected by in vivo MRS originates from intracellular and extracellular tissue 1998). The results of our study indicate that abnormalities in (Prichard, 1991; Arnold and Matthews, 1996) . Thus, increased probably indicative of cerebral mitochondrial dysfunction (Matthews et al., 1993; De Stefano et al., 1995b) . Recently, resonance intensities of La can reflect primary or secondary impairment of mitochondrial metabolism or infiltration of morphological and biochemical evidence of mitochondrial dysfunction (probably secondary to the toxic effect of high macrophages and inflammatory cells (Prichard, 1991) . In the latter case, however, La resonance intensities increase cholestanol and/or bile alcohol levels) have been reported in patients with CTX (Federico et al., 1991; . transiently in pathologically active brain regions and are often limited to the lesion and the surrounding area (Arnold Thus, the results of the present study add to these previous data in suggesting the presence of a diffuse impairment of et De Stefano et al., 1995a) . In contrast, an extensive and diffuse pathological increase in brain La is mitochondrial oxidative metabolism in CTX patients. Finally, overestimated NAA and thus underestimated the differences with respect to control subjects. In addition, it should be mentioned that the relatively long echo time does not allow accurate estimation of the lipid peaks in the brain volumes of interest. These are detected in positions 0.9 and 1.2 p.p.m. at this TE only with major accumulation (Arnold and Matthews, 1996; Narayana et al., 1998) . Thus, although contamination by lipids of the La signal cannot be excluded, the absence of a visible resonance intensity signal at 0.9 p.p.m. and the presence of the characteristic doublet of the La methyl resonance at 1.3 p.p.m. suggest that most of the signal is originating from brain La and that the amount of MR-visible lipids is not very significant in CTX patients. An important finding of the study was the close relationship Recent spectroscopic studies have demonstrated highly significant correlations between decreasing NAA and increasing clinical disability in patients with several it is interesting to note that the two patients who were not under pharmacological treatment showed the highest La/Cr neurological disorders (Davie et al., 1995; De Stefano et al., 1995a , 2000 Federico et al., 1998) . Thus, the results values, indirectly suggesting that an appropriate therapy does improve the brain metabolism in patients affected by CTX.
of the present study add to these previous studies in other neurological disorders in suggesting that the measure of In the present study, we did not attempt absolute quantification of our MRS data, and they were expressed as axonal loss provided by MRS can be a reliable surrogate marker of disease outcome. ratios with respect to Cr, assuming that this was present at a constant level. Although the resonance intensity of Cr has
In conclusion, our study suggests that abnormalities in the dentate nuclei can be revealed by FLAIR sequences with been widely used as an internal standard in in vivo MRS studies (Arnold and Matthews, 1996) , changes in apparent great sensitivity. On the basis of the present results, the bilateral hyperintensity of the dentate nuclei and surrounding brain Cr concentrations have been reported in patients with several white matter disorders in recent MRS studies white matter can be considered a neuradiological feature suggestive of CTX and could become an important diagnostic attempting absolute quantification (Davie et al., 1995; Frahm and Hanefeld, 1996; Sarchielli et al., 1999) . However, Cr marker in patients with incomplete or peculiar clinical manifestations of the disease. The decrease in NAA and appears to be refractory to changes in normal brains (Arnold and Matthews, 1996) and a study using high-resolution increase in La seen by MRS in the brains of patients with CTX indicate the presence of widespread axonal damage in vitro proton NMR spectroscopy (which does not suffer from the same limitations as in vivo quantification) has shown and mitochondrial dysfunction and may help to improve understanding of the dynamics of pathological changes that Cr levels are unchanged in the normal-appearing brain of patients with multiple sclerosis (Davies et al., 1995) . As occurring in this rare metabolic disorder. The strong correlation seen between the patients' clinical disability and the normal-appearing brain comprised the greatest portion of the brain volume of interest used for our MRS studies, we the putative axonal marker NAA suggests that the marker provided by MRS could be useful in longitudinal studies believe that significant changes in Cr resonance intensities were unlikely. Consistent with this, ratios of Cho/Cr resonance monitoring response to therapy in CTX patients. intensities in the group of CTX patients did not differ from those of normal controls.
With the relatively long echo time (TE ϭ 272 ms) used metabolites or a trend for prolonged T 2 of NAA in pulse sequence in assessment of central nervous system involvement pathological brains (Wilkinson et al., 1994; Christiansen in myotonic dystrophy. Neuroradiology 1998; 40: 32-5. et al., 1995; van der Toorn et al., 1995; Cady, 1996; Fujimori et al., 1998; Sarchielli et al., 1999 
